Aerobic and breathing exercises improve dyspnea, exercise capacity and quality of life in idiopathic pulmonary fibrosis patients: systematic review and meta-analysis

Masatoshi Hanada, Karina Tamy Kasawara, Sunita Mathur, Dmitry Rozenberg, Ryo Kozu, S Ahmed Hassan, W Darlene Reid, Masatoshi Hanada, Karina Tamy Kasawara, Sunita Mathur, Dmitry Rozenberg, Ryo Kozu, S Ahmed Hassan, W Darlene Reid

Abstract

Background: Idiopathic pulmonary fibrosis (IPF) is a progressive disease associated with significant dyspnea and limited exercise capacity. This systematic review aimed to synthesize evidence of exercise interventions during pulmonary rehabilitation that aim to improve exercise capacity, dyspnea, and health-related quality of life (HRQL) in IPF patients.

Methods: Searches were performed in MEDLINE, Embase, CENTRAL, SPORTDiscus, PubMed and PEDro from inception to January 2019 using search terms for: (I) participants: 'IPF or interstitial lung disease'; (II) interventions: 'aerobic training or resistance training or respiratory muscle training'; and (III) outcomes: 'exercise capacity or dyspnea or health-related quality of life'. Two reviewers independently screened titles, abstracts and full texts to identify eligible studies. Methodological quality of studies was assessed using the Downs and Black checklist and meta-analyses were performed.

Results: Of 1,677 articles identified, 14 were included (four randomized controlled trials and 10 prospective pre-post design studies) that examined 362 patients receiving training and 95 control subjects. Exercise capacity was measured with the 6-minute walk distance, peak oxygen consumption, peak work rate, or endurance time for constant work rate cycling, which increased after exercise [aerobic exercise; aerobic and breathing exercises; aerobic and inspiratory muscle training (IMT) exercises] compared to the control groups. Dyspnea scores improved after aerobic and breathing exercises. HRQL also improved after aerobic exercise training alone or combined with breathing exercises. Aerobic training alone or combined with IMT or breathing exercises improved exercise capacity.

Conclusions: Breathing exercises appears to complement exercise training towards improved dyspnea and HRQL in patients with IPF.

Keywords: Dyspnea; exercise; interstitial lung diseases; quality of life; rehabilitation.

Conflict of interest statement

Conflicts of Interest: The authors have no conflicts of interest to declare.

2020 Journal of Thoracic Disease. All rights reserved.

Figures

Figure 1
Figure 1
Flow chart of retrieval, screening and inclusion of articles in systematic review.
Figure 2
Figure 2
Change in 6-minute walk distance (m). (A) Exercise versus control; (B) pre and post exercise. Symbols: for single studies, the squares indicate the mean difference and the relative size of the square is an indication of the weighting of this study towards the overall effect. The endpoints of the horizontal lines are the upper and lower 95% confidence interval. The large diamonds represent the summed data for the subgroups and all studies included in the meta-analysis; the midpoint of the diamond indicates the mean difference whereas the endpoints are the upper and lower 95% confidence interval. 95% CI, 95-percent confidence interval; IV, inverse variance; SD, standard deviation.
Figure 3
Figure 3
Change in cycle ergometry outcome. (A) Peak work rate (watt)—exercise versus control; (B) peak work rate (watt)—pre and post exercise; (C) constant work rate endurance time (s)—exercise versus control; (D) Constant work rate endurance time (s)—pre and post exercise. Symbols: for single studies, the squares indicate the mean difference and the relative size of the square is an indication of the weighting of this study towards the overall effect. The endpoints of the horizontal lines are the upper and lower 95% confidence interval. The large diamonds represent the summed data for the subgroups and all studies included in the meta-analysis; the midpoint of the diamond indicates the mean difference whereas the endpoints are the upper and lower 95% confidence interval. 95% CI, 95-percent confidence interval; IV, inverse variance; SD, standard deviation.
Figure 4
Figure 4
Change in dyspnea score. (A) Exercise versus control; (B) % improvement of pre and post exercise. Symbols: for single studies, the squares indicate the mean difference and the relative size of the square is an indication of the weighting of this study towards the overall effect. The endpoints of the horizontal lines are the upper and lower 95% confidence interval. The large diamonds represent the summed data for the subgroups and all studies included in the meta-analysis; the midpoint of the diamond indicates the mean difference whereas the endpoints are the upper and lower 95% confidence interval. 95% CI, 95-percent confidence interval; IV, inverse variance; SD, standard deviation.
Figure 5
Figure 5
Change in St. George’s Respiratory Questionnaire (point). (A) Exercise versus control; (B) Pre and post exercise. Symbols: for single studies, the squares indicate the mean difference and the relative size of the square is an indication of the weighting of this study towards the overall effect. The endpoints of the horizontal lines are the upper and lower 95% confidence interval. The large diamonds represent the summed data for the subgroups and all studies included in the meta-analysis; the midpoint of the diamond indicates the mean difference whereas the endpoints are the upper and lower 95% confidence interval. 95% CI, 95-percent confidence interval; IV, inverse variance; SD, standard deviation.
Figure 6
Figure 6
The 36-item Short-Form Health Survey (SF-36) pre versus post-exercise. Symbols: for single studies, the squares indicate the mean difference and the relative size of the square is an indication of the weighting of this study towards the overall effect. The endpoints of the horizontal lines are the upper and lower 95% confidence interval. The large diamonds represent the summed data for the subgroups and all studies included in the meta-analysis; the midpoint of the diamond indicates the mean difference whereas the endpoints are the upper and lower 95% confidence interval. 95% CI, 95-percent confidence interval; IV, inverse variance; SD, standard deviation.

References

    1. Oldham JM, Noth I. Idiopathic pulmonary fibrosis: early detection and referral. Respir Med 2014;108:819-29. 10.1016/j.rmed.2014.03.008
    1. Hutchinson J, Fogarty A, Hubbard R, et al. Global incidence and mortality of idiopathic pulmonary fibrosis: a systematic review. Eur Respir J 2015;46:795-806. 10.1183/09031936.00185114
    1. Raghu G, Collard HR, Egan JJ, et al. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 2011;183:788-824. 10.1164/rccm.2009-040GL
    1. Kenn K, Gloeckl R, Behr J. Pulmonary rehabilitation in patients with idiopathic pulmonary fibrosis--a review. Respiration 2013;86:89-99. 10.1159/000354112
    1. Spruit MA, Singh SJ, Garvey C, et al. An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation. Am J Respir Crit Care Med 2013;188:e13-64. 10.1164/rccm.201309-1634ST
    1. Swigris JJ, Stewart AL, Gould MK, et al. Patients' perspectives on how idiopathic pulmonary fibrosis affects the quality of their lives. Health Qual Life Outcomes. 2005;3:61. 10.1186/1477-7525-3-61
    1. Perez-Bogerd S, Wuyts W, Barbier V, et al. Short and long-term effects of pulmonary rehabilitation in interstitial lung diseases: a randomised controlled trial. Respir Res 2018;19:182. 10.1186/s12931-018-0884-y
    1. Dowman L, Hill CJ, Holland AE. Pulmonary rehabilitation for interstitial lung disease. Cochrane Database Syst Rev 2014;(10):CD006322.
    1. Kozu R, Senjyu H, Jenkins SC, et al. Differences in response to pulmonary rehabilitation in idiopathic pulmonary fibrosis and chronic obstructive pulmonary disease. Respiration 2011;81:196-205. 10.1159/000315475
    1. Vainshelboim B. Exercise training in idiopathic pulmonary fibrosis: is it of benefit? Breathe (Sheff) 2016;12:130-8. 10.1183/20734735.006916
    1. Puglisi S, Torrisi SE, Vindigni V, et al. New perspectives on management of idiopathic pulmonary fibrosis. Ther Adv Chronic Dis. 2016;7:108-20. 10.1177/2040622315624276
    1. Holland A, Hill C. Physical training for interstitial lung disease. Cochrane Database Syst Rev 2008;(4):CD006322.
    1. Gomes-Neto M, Silva CM, Ezequiel D, et al. Impact of pulmonary rehabilitation on exercise tolerance and quality of life in patients with idiopathic pulmonary fibrosis: A systematic review and meta-analysis. J Cardiopulm Rehabil Prev 2018;38:273-8. 10.1097/HCR.0000000000000273
    1. Holland AE, Hill CJ, Jones AY, et al. Breathing exercises for chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2012;10:CD008250.
    1. Beaumont M, Forget P, Couturaud F, et al. Effects of inspiratory muscle training in COPD patients: A systematic review and meta-analysis. Clin Respir J 2018;12:2178-88. 10.1111/crj.12905
    1. Reid WD, Loveridge BM. Physiotherapy management of patients with chronic obstructive airways disease. Physiother Can 1983;35:183-95.
    1. Parisien-La Salle S, Abel Rivest E, Boucher VG, et al. Effects of Pursed Lip Breathing on Exercise Capacity and Dyspnea in Patients With Interstitial Lung Disease: A randomized, crossover study. J Cardiopulm Rehabil Prev 2019;39:112-7. 10.1097/HCR.0000000000000387
    1. Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement. Open Med 2009;3:e123-30.
    1. ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories . ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002;166:111-7. 10.1164/ajrccm.166.1.at1102
    1. Muza SR, Silverman MT, Gilmore GC, et al. Comparison of scales used to quantitate the sense of effort to breathe in patients with chronic obstructive pulmonary disease. Am Rev Respir Dis 1990;141:909-13. 10.1164/ajrccm/141.4_Pt_1.909
    1. Fletcher C.M, Elmes P.C, Fairbairn A.S, et al. The significance of respiratory symptoms and the diagnosis of chronic bronchitis in a working population. Br Med J 1959;2:257-66. 10.1136/bmj.2.5147.257
    1. Mahler DA, Wells CK. Evaluation of clinical methods for rating dyspnea. Chest 1988;93:580-6. 10.1378/chest.93.3.580
    1. Mahler DA, Weinberg DH, Wells CK, et al. The measurement of dyspnea. Contents, interobserver agreement, and physiologic correlates of two new clinical indexes. Chest 1984;85:751-8. 10.1378/chest.85.6.751
    1. Hayes MHS, Patterson D. Experimental development of the graphic rating method. Psychol Bull 1921;18:98-9.
    1. Jones PW, Quirk FH, Baveystock CM, et al. A self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire. Am Rev Respir Dis 1992;145:1321-7. 10.1164/ajrccm/145.6.1321
    1. Yorke J, Jones PW, Swigris JJ. Development and validity testing of an IPF-specific version of the St George's Respiratory Questionnaire. Thorax 2010;65:921-6. 10.1136/thx.2010.139121
    1. Ware JE, Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992;30:473-83. 10.1097/00005650-199206000-00002
    1. Downs SH, Black N. The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions. J Epidemiol Community Health 1998;52:377-84. 10.1136/jech.52.6.377
    1. Munn J, Sullivan SJ, Schneiders AG. Evidence of sensorimotor deficits in functional ankle instability: a systematic review with meta-analysis. J Sci Med Sport 2010;13:2-12. 10.1016/j.jsams.2009.03.004
    1. Melsen WG, Bootsma MC, Rovers MM, et al. The effects of clinical and statistical heterogeneity on the predictive values of results from meta-analyses. Clin Microbiol Infect 2014;20:123-9. 10.1111/1469-0691.12494
    1. Dowman LM, McDonald CF, Hill CJ, et al. The evidence of benefits of exercise training in interstitial lung disease: a randomised controlled trial. Thorax 2017;72:610-9. 10.1136/thoraxjnl-2016-208638
    1. da Fontoura FF, Berton DC, Watte G, Florian J, et al. Pulmonary rehabilitation in patients with advanced idiopathic pulmonary fibrosis referred for lung transplantation. J Cardiopulm Rehabil Prev 2018;38:131-4. 10.1097/HCR.0000000000000315
    1. Kozu R, Jenkins S, Senjyu H. Effect of disability level on response to pulmonary rehabilitation in patients with idiopathic pulmonary fibrosis. Respirology 2011;16:1196-202. 10.1111/j.1440-1843.2011.02029.x
    1. Ozalevli S, Karaali HK, Ilgin D, et al. Effect of home-based pulmonary rehabilitation in patients with idiopathic pulmonary fibrosis. Multidiscip Respir Med 2010;5:31-7. 10.1186/2049-6958-5-1-31
    1. Nishiyama O, Kondoh Y, Kimura T, et al. Effects of pulmonary rehabilitation in patients with idiopathic pulmonary fibrosis. Respirology 2008;13:394-9. 10.1111/j.1440-1843.2007.01205.x
    1. Jackson RM, Gomez-Marin OW, Ramos CF, et al. Exercise limitation in IPF patients: a randomized trial of pulmonary rehabilitation. Lung 2014;192:367-76. 10.1007/s00408-014-9566-9
    1. Vainshelboim B, Oliveira J, Yehoshua L, et al. Exercise training-based pulmonary rehabilitation program is clinically beneficial for idiopathic pulmonary fibrosis. Respiration 2014;88:378-88. 10.1159/000367899
    1. Swigris JJ, Fairclough DL, Morrison M, et al. Benefits of pulmonary rehabilitation in idiopathic pulmonary fibrosis. Respir Care 2011;56:783-9. 10.4187/respcare.00939
    1. Rammaert B, Leroy S, Cavestri B, et al. Home-based pulmonary rehabilitation in idiopathic pulmonary fibrosis. Rev Mal Respir 2011;28:e52-7. 10.1016/j.rmr.2011.06.006
    1. Arizono S, Taniguchi H, Sakamoto K, et al. Pulmonary rehabilitation in patients with idiopathic pulmonary fibrosis: comparison with chronic obstructive pulmonary disease. Sarco Vasc Dif lung dis 2017;34:283-289.
    1. Holland AE, Hill CJ, Glaspole I, et al. Predictors of benefit following pulmonary rehabilitation for interstitial lung disease. Respir Med 2012;106:429-35. 10.1016/j.rmed.2011.11.014
    1. Rifaat N, Anwar E, Ali YM, et al. Value of pulmonary rehabilitation in patients with idiopathic pulmonary fibrosis. Egypt J Chest Dis Tuberc 2014;63:1013-7. 10.1016/j.ejcdt.2014.06.004
    1. Arizono S, Taniguchi H, Sakamoto K, et al. Endurance time is the most responsive exercise measurement in idiopathic pulmonary fibrosis. Respir Care 2014;59:1108-15. 10.4187/respcare.02674
    1. du Bois RM, Weycker D, Albera C, et al. Six-minute-walk test in idiopathic pulmonary fibrosis: test validation and minimal clinically important difference. Am J Respir Crit Care Med 2011;183:1231-7. 10.1164/rccm.201007-1179OC
    1. Nykvist SM, Ferrara G, Faager G. Inspiratory muscle training in addition to physical exercise for idiopathic pulmonary fibrosis. Eur Respir J 2016;48:OA1518.
    1. O'Donnell DE, D'Arsigny C, Webb KA. Effects of hyperoxia on ventilatory limitation during exercise in advanced chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001;163:892-8. 10.1164/ajrccm.163.4.2007026
    1. Ryerson CJ, Cayou C, Topp F, et al. Pulmonary rehabilitation improves long-term outcomes in interstitial lung disease: a prospective cohort study. Respir Med 2014;108:203-10. 10.1016/j.rmed.2013.11.016
    1. Verma G, Marras T, Chowdhury N, et al. Health-related quality of life and 6 minute walk distance in patients with idiopathic pulmonary fibrosis. Can Respir J 2011;18:283-7. 10.1155/2011/109635
    1. Jones PW. St. George's Respiratory Questionnaire: MCID. COPD 2005;2:75-9. 10.1081/COPD-200050513

Source: PubMed

3
Subscribe